Rating Change
Mizuho analysts reiterated a Outperform rating on The Chemours Company (NYSE:CC) on July 01, 2026.
reiterateNYSE:CC
Mizuho Reiterates Outperform Rating on The Chemours Company (CC)
Rating Change Mizuho analysts reiterated a Outperform rating on The Chemours Company (NYSE:CC) on July 01, 2026. Market Context The Chemours Company operates in the Basic…
Market Context
The Chemours Company operates in the Basic Materials sector. The stock currently trades at $20.14 with a market capitalization of $2.0B. The stock has gained 47.8% over the past 52 weeks.
Analyst coverage from Mizuho provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for The Chemours Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for The Chemours Company
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 01, 2026 | Mizuho | Outperform | N/A |
| May 21, 2026 | JP Morgan | Neutral | N/A |
| May 11, 2026 | RBC Capital | Outperform | N/A |
| May 11, 2026 | Morgan Stanley | Equal-Weight | N/A |
| May 08, 2026 | UBS | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CC Stock Page
Frequently Asked Questions
What does a Outperform rating mean for CC?
A Outperform rating from Mizuho reflects the analyst's outlook on The Chemours Company (NYSE:CC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CC forecast page.